Rifaximin
Showing 51 - 75 of 237
Hepatic Encephalopathy, Liver Cirrhosis, End Stage Liver DIsease Trial (E.coli Nissle 1917, Lactulose, Rifaximin)
Completed
- Hepatic Encephalopathy
- +2 more
- E.coli Nissle 1917
- +2 more
- (no location specified)
Mar 5, 2021
Nonalcoholic Fatty Liver Disease, NAFLD, Nonalcoholic Steatohepatitis Trial in London (Rifaximin)
Terminated
- Nonalcoholic Fatty Liver Disease
- +2 more
- Rifaximin
-
London, United KingdomLiver Unit, St Mary's Hospital, Imperial College London
Oct 5, 2020
Overt Hepatic Encephalopathy Trial in United States (40 mg Rifaximin SSD once daily, 40 mg Rifaximin SSD twice daily, 80 mg
Completed
- Overt Hepatic Encephalopathy
- 40 mg Rifaximin SSD once daily
- +5 more
-
Corona Del Mar, California
- +33 more
Mar 10, 2021
Parkinson Disease Trial in Warsaw (Fecal Microbiota Transfer)
Enrolling by invitation
- Parkinson Disease
- Fecal Microbiota Transfer
-
Warsaw, PolandDepartment of Neurology, Faculty of health sciences, Medical Uni
Jan 10, 2022
Hepatic Cirrhosis, Hepatic Encephalopathy (HE) Trial in Puerto Rico, United States (MNK6106, Rifaximin)
Completed
- Hepatic Cirrhosis
- Hepatic Encephalopathy (HE)
- MNK6106
- Rifaximin
-
Coronado, California
- +4 more
Jun 29, 2021
Irritable Bowel Syndrome, Fecal Microbiota Transplantation Trial in Guangzhou (fecal microbiota transplantation, Infusion of
Recruiting
- Irritable Bowel Syndrome
- Fecal Microbiota Transplantation
- fecal microbiota transplantation
- +2 more
-
Guangzhou, Guangdong, ChinaGuangzhou First People's Hospital
Aug 1, 2021
Parkinson's Disease Aggravated Trial in Leon (sodium phosphate enema, oral rifaximin and polyethylene glycol)
Completed
- Parkinson's Disease Aggravated
- sodium phosphate enema, oral rifaximin and polyethylene glycol
-
Leon, Guanajuato, MexicoTorre Medica Sante
Jan 25, 2021
Diverticulitis Trial in Worldwide (Rifaximin delayed released 400mg Tablet, Placebo)
Terminated
- Diverticulitis
- Rifaximin delayed released 400mg Tablet
- Placebo
-
Bobigny, France
- +63 more
Oct 13, 2021
Small Bowel Disease, Rifaximin Trial in Beijing, Hong Kong (Rifaximin, Placebo oral tablet)
Recruiting
- Small Bowel Disease
- Rifaximin
- Rifaximin
- Placebo oral tablet
-
Beijing, Beijing, China
- +1 more
Jun 29, 2020
Decompensated Cirrhosis, Small Bowel Bacterial Overgrowth Syndrome Trial in Singapore (Rifaximin)
Recruiting
- Decompensated Cirrhosis
- Small Bowel Bacterial Overgrowth Syndrome
- Rifaximin
-
Singapore, SingaporeWong Yu Jun
Feb 25, 2021
IBS - Irritable Bowel Syndrome, Gut Microbiota Trial in Hangzhou (Rifaximin, Probiotic Formula, Placebo oral tablet)
Unknown status
- IBS - Irritable Bowel Syndrome
- Gut Microbiota
- Rifaximin
- +2 more
-
Hangzhou, Zhejiang, ChinaThe Second Affiliated Hospital, School of Medicine, Zhejiang Uni
Jul 26, 2020
Cirrhosis Trial in France (Rifaximin, )
Completed
- Cirrhosis
- Rifaximin
- placebo
-
Angers, France
- +12 more
Apr 21, 2020
Dyspepsia Trial in Lucknow (Rifaximin, Placebo)
Not yet recruiting
- Dyspepsia
- Rifaximin
- Placebo
-
Lucknow, UP, India
- +1 more
Mar 6, 2020
Diarrhea Trial in Guadalajara (Rifaximin, Placebo)
Completed
- Diarrhea
- Rifaximin
- Placebo
-
Guadalajara, Jalisco, MexicoUniversity of San Diego
Dec 3, 2019
Pharmacokinetic Trial (rifaximin)
Completed
- Pharmacokinetic
- rifaximin
- (no location specified)
Nov 26, 2019
Diarrhea Trial in South Miami, Houston, La Porte (Rifaximin)
Completed
- Diarrhea
- Rifaximin
-
South Miami, Florida
- +2 more
Nov 21, 2019
Hepatic Encephalopathy Trial in Miami (Rifaximin, Lactulose, Placebo)
Terminated
- Hepatic Encephalopathy
- Rifaximin
- +2 more
-
Miami, FloridaCenter For Liver Diseases - University of Miami
Aug 27, 2019
Hepatic Encephalopathy Trial in Hangzhou (Fecal Microbiota Transplantation)
Active, not recruiting
- Hepatic Encephalopathy
- Fecal Microbiota Transplantation
-
Hangzhou, Zhejiang, ChinaShulan (Hangzhou) Hospital
Dec 29, 2022
Travelers' Diarrhea, Functional Bowel Disorders, Reactive Arthritis Trial in Kenya, United States (Rifaximin, Placebo)
Unknown status
- Travelers' Diarrhea
- +2 more
- Rifaximin
- Placebo
-
San Diego, California
- +5 more
Nov 25, 2019
Obese, Insulin Resistance, Metabolic Syndrome Trial in Lexington (Rifaximin SSD, Placebo)
Completed
- Obese
- +2 more
- Rifaximin SSD
- Placebo
-
Lexington, KentuckyUniversity of Kentucky Center for Clinical and Translational Sci
Aug 6, 2019
Refractory Hepatic Encephalopathy Trial in New Delhi (Lactulose, Rifaximin, Plasmapheresis)
Withdrawn
- Refractory Hepatic Encephalopathy
- Lactulose
- +2 more
-
New Delhi, Delhi, IndiaInstitute of Liver and Biliary Sciences
Nov 1, 2019